The FDA’s decision to approve the drug, siding with industry and patient advocates, raises new questions about whether it is lowering its burden of proof for drugmakers.
Related posts:
Virginia, Maryland lift mask mandates
Nursing homes invoke Trump-era protections to fight lawsuits over Covid deaths
Biden admin recommends Covid-19 booster shots for all Americans
Health worker crunch pressures states battling Delta variant
Tensions mount between CDC and Biden health team over boosters
Mississippi’s governor criticizes Biden’s vaccine mandate while suggesting people vaccinate
U.S. Covid death toll hits 800,000, a year into vaccine drive
Biden plans to expand testing and reinforce hospitals facing Omicron
Hospitals grapple with Omicron — and legal brawl over vaccinating staff
Gaps remain in safety data on State Veterans Homes
Biden looks to reassure governors amid Omicron surge and long lines for tests
Beijing district orders mass virus testing ahead of Olympics
